Eight patients with pancreatic neoplasia were confirmed by surgery or fine-needle aspiration (10% yield of screening); of these, six patients had benign intraductal papillary mucinous neoplasms (IPMNs), one had an IPMN that progressed to invasive ductal adenocarcinoma, and one had a PanIN-1.
The Food and Drug Administration has approved Velcade to treat a type of cancer called multiple myeloma. Velcade should only be used in people who have already been treated with two other types of chemotherapy (drugs used to kill cancer cells), and whose cancer has still progressed on the most recent therapy.Velcade is a new type of cancer drug called a proteasome inhibitor.Proteasomes are enzymes found in cells, and play a role in regulating cell function and growth. Velcade blocks the activity of proteasomes. This blockade can lead to death of cancer cells.elcade is a new type of cancer drug called a proteasome inhibitor. Proteasomes are enzymes found in cells, and play a role in regulating cell function and growth. Velcade blocks the activity of proteasomes. This blockade can lead to death of cancer cells.
Amgenâs experimental Repatha drug lowers cholesterol by 60 percent, according to FDA reviewers. The injectable drug is one of a new class of drugs considered the first major advance in lowering bad cholesterol in 20 years.hile Amgen will not discuss pricing plans for Repatha â and the FDA is barred from considering cost when reviewing drugs â Express Scripts and other companies are already raising concerns about the impact on health care budgets.